Fatigue in cancer patients in palliative care—a review on pharmacological interventions

24Citations
Citations of this article
73Readers
Mendeley users who have this article in their library.

Abstract

Fatigue is one of the most distressing symptoms experienced by cancer patients. The suggested biological mechanism for cancer related fatigue (CRF) includes immune activation triggered by tumor tissue or by anticancer treatment but other mechanisms have also been proposed. Previous large meta‐analysis of interventions on fatigue focuses mostly on patients early in the disease trajectory, with only one tenth of included studies performed in palliative cohorts. The aim of this narrative review is therefore to present a background on CRF with focus on the palliative setting. A summary of recent randomized, controlled trials on pharmacological interventions on CRF in palliative care is presented, including studies on psychostimulants, corticosteroids, testosterone and melatonin. Interestingly, in several of these studies there was a positive and similar effect on fatigue in both the intervention and the placebo arm—indicating an important placebo effect for any pharmacological treatment. In addition, studies on dietary supplements and on pharmacological complementary medicines are discussed. To conclude, the evidence is still weak for using pharmacological treatments on CRF in palliative care patients— although methylphenidate and corticosteroids might be considered.

Cite

CITATION STYLE

APA

Klasson, C., Frankling, M. H., Hagelin, C. L., & Björkhem‐bergman, L. (2021, March 1). Fatigue in cancer patients in palliative care—a review on pharmacological interventions. Cancers. MDPI AG. https://doi.org/10.3390/cancers13050985

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free